Modern approaches to pharmacotherapy of Community-Acquired Pneumonia
Authors
-
Anna A. Gavrilova
Multidisciplinary clinic “Harmony of Health” LLC ”MAXBelmed”
https://orcid.org/0000-0002-4335-5165
-
Roman A. Bontsevich
Children’s medical center “Azbuka Zdorovya”
https://orcid.org/0000-0002-9328-3905
-
Yana R. Vovk
Clinical and diagnostic center “Meditsina 31”
https://orcid.org/0000-0002-7741-9745
-
Anastasia A. Balabanova
Saint Joasaph Belgorod Regional Hospital
https://orcid.org/0000-0002-2987-8082
DOI:
https://doi.org/10.3897/rrpharmacology.6.52318Abstract
Introduction: The study presents current views on the pharmacotherapy of community-acquired pneumonia (CAP). This study also describes in general terms the current pharmacoepidemiological situation of the CAP in Russia and abroad, which can both help medical professionals make an informed choice when choosing a pharmacotherapy, and inspire them to follow-up research and observations.
The aim of the study is to conduct an analysis of the available research on the pharmacotherapy of CAP in order to accelerate the accumulation and assimilation of knowledge in the field of this pathology.
Materials and methods: The following databases of medical publications and electronic libraries were used to search for the relevant sources of information: PubMed, Medline, Google Scholar, Crossref, and eLIBRARY.RU.
Results and discussion: The choice of a rational antimicrobial therapy (AMT) for CAP is of high relevance due to the widespread of the pathology. The article highlights modern approaches to the pharmacotherapy of CAP in adults, including a review of promising new drugs, and presents the main problematic issues related to the emergence of antibiotic resistance of pathogens, as well as methods to combat it.
Conclusion: The analyzed and generalized results of the conducted research allow the authors to make a conclusion about the feasibility of a more detailed study and raising the level of awareness of medical professionals in this pathology.
Русский
English
